Maximilian G
closes Dec 31
16%
chance
1D
1W
1M
ALL
Resolves to YES if a vaccine that was widely administered (more than 1 million doses) is pulled off the market due to safety concerns in at least one OECD country, at any point in 2023.
Otherwise resolves to NO.
The term "pulled off the market" does not apply if rollout is only temporarily paused for 30 days or less.
Sort by:
jackson polack
does something like https://www.nbcnews.com/news/us-news/johnson-johnson-vaccine-should-be-paused-u-s-after-extremely-n1263898 count as 'being pulled off the market due to safety concerns'?
Maximilian G
@jacksonpolack The term "pulled off the market" does not apply if rollout is only temporarily paused for 30 days or less.
Sort by:
YES payouts
Ṁ69
NO payouts
Ṁ65
Ṁ61
Ṁ22
Ṁ19
Ṁ13
Ṁ12
Ṁ12
Ṁ12
Ṁ11
Related markets
Brian T. Edwards
Will China's FDA grant approval to an mRNA COVID vaccine by the end of 2023?68%
Aaron Kaufman
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?20%
Gavriel
Will development of a universal flu vaccine have made significant progress by 2026?62%
Related markets
Brian T. Edwards
Will China's FDA grant approval to an mRNA COVID vaccine by the end of 2023?68%
Aaron Kaufman
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?20%
Gavriel
Will development of a universal flu vaccine have made significant progress by 2026?62%